DXC · DXC Technology Company

The thesis

DXC Technology's recovery case now rests on the fiscal second-quarter report, estimated for 29 October 2026, after the shares rose 16.4% in ten sessions with no confirming business result. The adjusted close was $12.40 on 9 October 2026, up from $10.65 on 25 September 2026. The report must show revenue inside the guided $2.970–$3.000 billion range and fiscal 2027 non-GAAP diluted earnings guidance of $2.40–$2.90 per share intact.

The price has moved ahead of the evidence. DXC reported fiscal first-quarter revenue of $2.999 billion on 30 July 2026, down 6.7% organically, while bookings rose 5% to $3.0 billion. TD Cowen kept a Hold rating on 9 July 2026 and lowered its price target to $10, below the current close. The narrative is re-accelerating in price: the 17 September 2026 LOXO partnership was the last quantified-free product headline, and no company release dated between 25 September 2026 and 9 October 2026 that accounts for the move was located.

Bullish and bearish views on DXC Technology Company

The bull case on DXC Technology Company (DXC), in brief: Another year-over-year increase at the September-quarter report would support the recovery reading. The bear case: Core revenue still shrinks.

Bull case

• Another year-over-year increase at the September-quarter report would support the recovery reading.
• Annual earnings guidance is intact. Management kept fiscal 2027 non-GAAP diluted earnings guidance at $2.40–$2.90 per share on 30 July 2026. Holding that range at the next report keeps the operating floor under the shares.
• The product list has widened. DXC announced Workplace Services on 12 August 2026, an ElevenLabs voice-AI partnership on 28 July 2026 and a LOXO autonomous-trucking engineering partnership on 17 September 2026. None disclosed contract value or revenue timing.
• The shares have recovered much of the drawdown. The $12.40 close on 9 October 2026 is 19.6% below the 52-week high of $15.43, and the shares gained 35.4% over three months, per adjusted daily closes.

Bear case

• Core revenue still shrinks. Fiscal first-quarter revenue fell 5.1% reported and 6.7% organically (DXC, 30 July 2026). Management guided September-quarter organic revenue to a further decline of 5.5%–6.5%.
• Cash flow includes a one-time item. First-quarter free cash flow was $314 million, of which $214 million was litigation proceeds (DXC, 30 July 2026). The roughly $685 million fiscal 2027 cash-flow forecast was raised to reflect litigation-related matters.
• The price sits above the one published analyst target. TD Cowen's $10 target (9 July 2026) is below the $12.40 close. Other firms' recent changes were not located for this note.
• The move lacks a new fact behind it. The 14-day relative strength index was 69.9 on 9 October 2026, against 36.2 on 25 September 2026, a swing driven by price rather than by a filed number.

Price setup

The adjusted close was $12.40 on 9 October 2026. The 52-week high is $15.43, 19.6% above that close. The 11 September 2026 reference close was $11.39, and the 25 September 2026 close was $10.65. The shares have therefore more than recovered the September decline.

The published weekly-close break level of $10.50 sits 15.3% below the current close. A 14-day relative strength index near 70 marks the shares as close to overbought by that conventional measure.

Crowding evidence is limited to what can be observed: a 16.4% gain in ten sessions, an earnings report about three weeks away, and an options-implied earnings move of roughly 15% in either direction, according to Unusual Whales. No insider sales or share issuance were located.

Catalysts, next 30 days

• ~29 October 2026, est.: Fiscal second-quarter 2027 results. DXC had not confirmed the date in sources located. The report tests the $2.970–$3.000 billion revenue range, bookings, and the $2.40–$2.90 earnings guidance.

Elapsed catalysts

• 30 September 2026 (elapsed): DXC's fiscal second quarter ended. The company reports results only at its earnings release. (passed 21d ago)

What would change the view

The case breaks if September-quarter revenue lands below the $2.970 billion floor DXC guided on 30 July 2026, or if fiscal 2027 non-GAAP diluted earnings guidance is cut below $2.40 per share. A weekly close below $10.50 would also break the published recovery structure.

Disclosed revenue or bookings from Workplace Services, the ElevenLabs partnership or LOXO at the report would strengthen the case. A second consecutive year-over-year bookings increase with a ratio near or above 1.0 would do the same.

What it trades with

DXC trades with IT-services and outsourcing peers whose revenue is under pressure from client cost cuts and AI-driven automation. A sector move on AI disruption fears or relief would carry the shares in the same direction. Its debt and legacy-contract base make it more sensitive to rates and credit conditions than software names. No sector theme currently carries the shares.